Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $419.30 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IBSA Pharma Inc. | $222.98 | 12 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $124.97 | 1 | $0 (2023) |
| Teleflex LLC | $31.88 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23.84 | 1 | $0 (2017) |
| Allergan Inc. | $15.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.29 | 9 | IBSA Pharma Inc. ($156.41) |
| 2023 | $177.71 | 4 | NESTLE HEALTHCARE NUTRITION INC. ($124.97) |
| 2022 | $13.83 | 1 | IBSA Pharma Inc. ($13.83) |
| 2019 | $15.63 | 1 | Allergan Inc. ($15.63) |
| 2017 | $23.84 | 1 | Novartis Pharmaceuticals Corporation ($23.84) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.96 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Endocrinology | ||||||
| 08/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Endocrinology | ||||||
| 05/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Endocrinology | ||||||
| 02/19/2024 | Teleflex LLC | ARROW (Device) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 01/10/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $9.85 | General |
| Category: Endocrinology | ||||||
| 09/25/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: non-opioid analgesic | ||||||
| 08/16/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: non-opioid analgesic | ||||||
| 07/20/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $20.48 | General |
| Category: non-opioid analgesic | ||||||
| 03/23/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/25/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Endocrinology | ||||||
| 04/16/2019 | Allergan Inc. | LASTACAFT (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/10/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 158 | 270 | $123,036 | $27,067 |
| 2022 | 3 | 90 | 153 | $128,146 | $15,656 |
| 2021 | 3 | 83 | 120 | $99,512 | $11,433 |
| 2020 | 4 | 94 | 141 | $106,762 | $12,714 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 93 | 200 | $86,488 | $18,991 | 22.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 34 | $19,820 | $4,622 | 23.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 36 | $16,728 | $3,453 | 20.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 97 | $85,982 | $10,729 | 12.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 37 | $24,675 | $2,842 | 11.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 19 | $17,489 | $2,085 | 11.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 35 | 62 | $56,397 | $6,595 | 11.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 39 | $24,834 | $2,660 | 10.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 19 | 19 | $18,281 | $2,178 | 11.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 68 | $59,774 | $6,937 | 11.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 37 | $23,110 | $2,968 | 12.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 20 | $18,590 | $2,192 | 11.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 16 | $5,288 | $616.79 | 11.7% |
About Dr. Hyung Kim, M.D
Dr. Hyung Kim, M.D is a Hospitalist healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992970206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hyung Kim, M.D has received a total of $419.30 in payments from pharmaceutical and medical device companies, with $188.29 received in 2024. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($419.30).
As a Medicare-enrolled provider, Kim has provided services to 425 Medicare beneficiaries, totaling 684 services with total Medicare billing of $66,870. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine, Internal Medicine
- Location Vancouver, WA
- Active Since 04/28/2008
- Last Updated 11/20/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992970206
Products in Payments
- Tirosint (Drug) $170.24
- ZENPEP (Drug) $124.97
- LICART (Drug) $52.74
- ARROW (Device) $31.88
- ENTRESTO (Drug) $23.84
- LASTACAFT (Drug) $15.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Vancouver
Richard Kubiniec, M.d, M.D
Hospitalist — Payments: $3,144
Amar Bhuta, M.d, M.D
Hospitalist — Payments: $230.26
Yarun Nessa, Md, MD
Hospitalist — Payments: $16.81
Gordon Shyu, Do, DO
Hospitalist — Payments: $13.53
Dr. Kathleen Franco, M.d, M.D
Hospitalist
Michal Kremen, Md, MD
Hospitalist